BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24499676)

  • 1. PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson's disease mouse model.
    Youn JK; Kim DW; Kim ST; Park SY; Yeo EJ; Choi YJ; Lee HR; Kim DS; Cho SW; Han KH; Park J; Eum WS; Hwang HS; Choi SY
    BMB Rep; 2014 Oct; 47(10):569-74. PubMed ID: 24499676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of PEP-1-Catalase on stress-induced cellular toxicity and MPTP-induced Parkinson's disease.
    Eom SA; Kim DW; Shin MJ; Ahn EH; Chung SY; Sohn EJ; Jo HS; Jeon SJ; Kim DS; Kwon HY; Cho SW; Han KH; Park J; Eum WS; Choi SY
    BMB Rep; 2015 Jul; 48(7):395-400. PubMed ID: 25322954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEP-1-heat shock protein 27 protects from neuronal damage in cells and in a Parkinson's disease mouse model.
    Lee YP; Kim DW; Kang HW; Hwang JH; Jeong HJ; Sohn EJ; Kim MJ; Ahn EH; Shin MJ; Kim DS; Kang TC; Kwon OS; Cho SW; Park J; Eum WS; Choi SY
    FEBS J; 2012 Jun; 279(11):1929-42. PubMed ID: 22429328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model.
    Kim MJ; Park M; Kim DW; Shin MJ; Son O; Jo HS; Yeo HJ; Cho SB; Park JH; Lee CH; Kim DS; Kwon OS; Kim J; Han KH; Park J; Eum WS; Choi SY
    Biomaterials; 2015 Sep; 64():45-56. PubMed ID: 26117230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model.
    Ahn EH; Kim DW; Shin MJ; Kim YN; Kim HR; Woo SJ; Kim SM; Kim DS; Kim J; Park J; Eum WS; Hwang HS; Choi SY
    Free Radic Biol Med; 2013 Feb; 55():36-45. PubMed ID: 23178948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
    Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
    Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tat-fused recombinant human SAG prevents dopaminergic neurodegeneration in a MPTP-induced Parkinson's disease model.
    Sohn EJ; Shin MJ; Kim DW; Ahn EH; Jo HS; Kim DS; Cho SW; Han KH; Park J; Eum WS; Hwang HS; Choi SY
    Mol Cells; 2014 Mar; 37(3):226-33. PubMed ID: 24625574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
    Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
    Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
    Xu X; Song N; Wang R; Jiang H; Xie J
    Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
    Choi YJ; Kim DW; Shin MJ; Yeo HJ; Yeo EJ; Lee LR; Song Y; Kim DS; Han KH; Park J; Lee KW; Park JK; Eum WS; Choi SY
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34206041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.
    Ma X; Cao F; Cui J; Li X; Yin Z; Wu Y; Wang Q
    Mol Biol Rep; 2024 May; 51(1):669. PubMed ID: 38787465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP
    Wu KC; Liou HH; Lee CY; Lin CJ
    Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease.
    Ahn EH; Kim DW; Shin MJ; Kim HR; Kim SM; Woo SJ; Eom SA; Jo HS; Kim DS; Cho SW; Park J; Eum WS; Choi SY
    Biochim Biophys Acta; 2014 Jun; 1840(6):1686-700. PubMed ID: 24412329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease.
    Yun HM; Choi DY; Oh KW; Hong JT
    Mol Neurobiol; 2015 Aug; 52(1):422-31. PubMed ID: 25193021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted toxicants to dopaminergic neuronal cell death.
    Jin H; Kanthasamy A; Harischandra DS; Anantharam V; Rana A; Kanthasamy A
    Methods Mol Biol; 2015; 1254():239-52. PubMed ID: 25431070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
    Ren Y; Ye D; Ding Y; Wei N
    Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
    [No Abstract]   [Full Text] [Related]  

  • 19. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat-Frataxin protects dopaminergic neuronal cells against MPTP-induced toxicity in a mouse model of Parkinson's disease.
    Kim MJ; Kim DW; Jeong HJ; Sohn EJ; Shin MJ; Ahn EH; Kwon SW; Kim YN; Kim DS; Park J; Eum WS; Hwang HS; Choi SY
    Biochimie; 2012 Nov; 94(11):2448-56. PubMed ID: 22809528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.